What does a pattern of markedly elevated follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) with low serum testosterone and low or absent sperm count indicate, and how should primary (hypergonadotropic) testicular failure be evaluated and managed?

Primary Testicular Failure: Laboratory Pattern and Clinical Approach

Markedly elevated FSH and LH with low testosterone and low/absent sperm count indicates primary (hypergonadotropic) testicular failure—a condition where the testes themselves are damaged or dysfunctional and cannot respond to pituitary stimulation. 1, 2

Laboratory Pattern in Primary Testicular Failure

The characteristic hormonal profile reflects loss of negative feedback from the failing testes:

• Testosterone: Low (typically <300 ng/dL) 3, 2
• FSH: Markedly elevated (>7.6 IU/L) 4, 1
• LH: Markedly elevated 2, 5
• Sperm count: Severely reduced or absent (azoospermia or severe oligospermia <5 million/mL) 4, 1

The FSH threshold of >7.6 IU/L combined with testicular atrophy strongly indicates non-obstructive azoospermia and spermatogenic failure. 4, 1 This contrasts sharply with obstructive azoospermia, where FSH remains <7.6 IU/L and testicular size is normal. 4, 1

Physical Examination Findings

Testicular atrophy is the hallmark physical finding in primary testicular failure. 1, 2 This distinguishes it from obstructive causes where testes maintain normal size with dilated/indurated epididymides. 4, 1

Mandatory Genetic Evaluation

All men with primary testicular failure presenting with azoospermia or sperm concentration <5 million/mL require karyotype analysis and Y-chromosome microdeletion testing. 4, 1

Karyotype Testing

• Klinefelter syndrome (47,XXY) is the most common chromosomal abnormality causing primary testicular failure. 4, 1
• More severe variants (48,XXXY or 49,XXXXY) can occur 4
• Structural abnormalities including Robertsonian translocations may also impair spermatogenesis 4
• Approximately 4% of men with sperm concentration <5 million/mL have karyotype abnormalities 1

Y-Chromosome Microdeletion Testing

• Complete deletions of AZFa, AZFb, or AZFb/c regions (each occurring in 1-2% of non-obstructive azoospermia) result in inability to retrieve sperm by testicular sperm extraction (TESE). 1
• AZFc deletions (65-70% of Y-microdeletions) may still allow successful sperm retrieval 1
• Y-chromosome microdeletions occur in 5% of men with sperm concentrations 0-1 million/mL 4

Critical Diagnostic Pitfalls

Always centrifuge the ejaculate and re-examine the pellet microscopically—rare sperm may be present, changing the diagnosis from azoospermia to severe oligozoospermia. 4, 1 This distinction has significant implications for treatment options.

Normal FSH does NOT exclude non-obstructive azoospermia; men with maturation arrest can have normal FSH levels. 1 Do not rely solely on FSH for diagnosis.

Perform at least two semen analyses spaced one month apart when initial analysis shows abnormal parameters. 1

Management Approach

For Testosterone Replacement

Men with primary testicular failure who are not seeking fertility should receive testosterone replacement therapy. 3 Options include intramuscular injections, transdermal patches, or topical gel formulations. 3

For Fertility Preservation/Achievement

Genetic testing is mandatory before proceeding to TESE or intracytoplasmic sperm injection (ICSI), as detection of chromosomal translocations or Y-chromosome deletions influences therapeutic strategy and prognosis. 1

• Complete AZFa, AZFb, or AZFb/c deletions preclude successful sperm retrieval 1
• AZFc deletions may allow sperm retrieval for ICSI 1
• ICSI has emerged as treatment of choice for severe male factor infertility but carries higher risks of multiple gestation, low birth weight, preterm delivery, and chromosome aneuploidy compared to natural conception 2

Men considering ICSI should receive genetic counseling by counselors experienced in reproductive disorders. 2

Prognostic Indicators

Larger baseline testicular volume predicts successful sperm retrieval outcomes and earlier spermatogenesis induction. 6, 7 The testosterone-to-LH ratio is an additional independent predictor of successful sperm extraction in non-obstructive azoospermia. 7

Differential Consideration

If low testosterone occurs with LOW or inappropriately normal FSH/LH, this indicates secondary (hypogonadotropic) hypogonadism rather than primary testicular failure. 2 This distinction is critical because hypogonadotropic hypogonadism may be reversible with gonadotropin therapy (hCG with or without FSH), which can successfully induce spermatogenesis in 82% of cases. 6